Merck ends COVID-19 vaccine program, cites inferior immune responses
Published
Drugmaker Merck & Co on Monday said it will end development of its two COVID-19 vaccines, and will focus pandemic research on...
Full ArticlePublished
Drugmaker Merck & Co on Monday said it will end development of its two COVID-19 vaccines, and will focus pandemic research on...
Full ArticleHere’s what’s happening Monday with the coronavirus pandemic in the U.S.:
THREE THINGS TO KNOW TODAY
—..
A coronavirus mutation recently discovered in the UK has spread to other countries, including confirmed cases this week in the US,..
Merck will end development of its two Covid-19 vaccines, and will focus pandemic research on treatments.